First Time Loading...

Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 15.67 USD -2.79% Market Closed
Updated: May 29, 2024

Arcus Biosciences Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arcus Biosciences Inc
Accrued Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Arcus Biosciences Inc
NYSE:RCUS
Accrued Liabilities
$64m
CAGR 3-Years
28%
CAGR 5-Years
53%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Accrued Liabilities
$5.4B
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
8%
Amgen Inc
NASDAQ:AMGN
Accrued Liabilities
$14.1B
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accrued Liabilities
$2.8B
CAGR 3-Years
22%
CAGR 5-Years
39%
CAGR 10-Years
28%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accrued Liabilities
$2.4B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
28%

See Also

What is Arcus Biosciences Inc's Accrued Liabilities?
Accrued Liabilities
64m USD

Based on the financial report for Mar 31, 2024, Arcus Biosciences Inc's Accrued Liabilities amounts to 64m USD.

What is Arcus Biosciences Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
53%

Over the last year, the Accrued Liabilities growth was 31%. The average annual Accrued Liabilities growth rates for Arcus Biosciences Inc have been 28% over the past three years , 53% over the past five years .